These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35123077)

  • 1. Evaluating construct validity of the Asthma Impairment and Risk Questionnaire using a 3-month exacerbation recall.
    Chipps BE; Murphy KR; Wise RA; McCann WA; Beuther DA; Reibman J; George M; Gilbert I; Eudicone JM; Gandhi HN; Harding G; Ross M; Zeiger RS
    Ann Allergy Asthma Immunol; 2022 May; 128(5):544-552.e3. PubMed ID: 35123077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing meaningful change in the Asthma Impairment and Risk Questionnaire.
    McCann W; Murphy KR; Zeiger RS; Beuther DA; Wise RA; Reibman J; George M; Gilbert I; Eudicone JM; Gandhi HN; Cutts K; Coyne KS; Chipps B
    Ann Allergy Asthma Immunol; 2024 Aug; 133(2):152-158. PubMed ID: 38369256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship Between Asthma Control as Measured by the Asthma Impairment and Risk Questionnaire (AIRQ) and Patient Perception of Disease Status, Health-Related Quality of Life, and Treatment Adherence.
    Reibman J; Chipps BE; Zeiger RS; Beuther DA; Wise RA; McCann W; Gilbert I; Eudicone JM; Gandhi HN; Harding G; Cutts K; Coyne KS; Murphy KR; George M
    J Asthma Allergy; 2023; 16():59-72. PubMed ID: 36636702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma Exacerbations.
    Beuther DA; Murphy KR; Zeiger RS; Wise RA; McCann W; Reibman J; George M; Gilbert I; Eudicone JM; Gandhi HN; Ross M; Coyne KS; Chipps B
    J Allergy Clin Immunol Pract; 2022 Dec; 10(12):3204-3212.e2. PubMed ID: 35998877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Clinical Characteristics and Biomarkers on Asthma Impairment and Risk Questionnaire Exacerbation Prediction Ability.
    Murphy KR; Beuther DA; Chipps BE; Wise RA; McCann WA; Reibman J; George M; Gilbert I; Eudicone JM; Gandhi HN; Ross M; Coyne KS; Zeiger RS
    J Allergy Clin Immunol Pract; 2024 Aug; 12(8):2092-2101.e4. PubMed ID: 38705273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure.
    Murphy KR; Chipps B; Beuther DA; Wise RA; McCann W; Gilbert I; Eudicone JM; Gandhi HN; Harding G; Coyne KS; Zeiger RS;
    J Allergy Clin Immunol Pract; 2020; 8(7):2263-2274.e5. PubMed ID: 32387166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancing assessment of asthma control with a composite tool: The Asthma Impairment and Risk Questionnaire.
    Chipps BE; Zeiger RS; Beuther DA; Wise RA; McCann W; Reibman J; George M; Gilbert I; Eudicone JM; Coyne KS; Harding G; Murphy KR
    Ann Allergy Asthma Immunol; 2024 Jul; 133(1):49-56. PubMed ID: 38494113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma control.
    Chipps B; Zeiger RS; Beuther DA; Reibman J; Wise RA; McCann W; Gilbert I; Eudicone JM; Gandhi HN; Harding G; Cutts K; George M; Murphy KR
    Ann Allergy Asthma Immunol; 2023 Oct; 131(4):436-443.e1. PubMed ID: 37105501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the German version of the Asthma Impairment and Risk Questionnaire (AIRQ).
    Kanniess F; Defosse K; Lommatzsch M; Schultz T; Timmermann H; Schmidt O; Heindl S; Baumann HJ; Buhl R; Taube C; Höing F; Korn S
    Pneumologie; 2024 Nov; 78(11):912-921. PubMed ID: 38991526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of exacerbations on St George's Respiratory Questionnaire score in patients with severe asthma: post hoc analyses of two clinical trials and an observational study.
    Nelsen LM; Cockle SM; Gunsoy NB; Jones P; Albers FC; Bradford ES; Mullerova H
    J Asthma; 2020 Sep; 57(9):1006-1016. PubMed ID: 31251094
    [No Abstract]   [Full Text] [Related]  

  • 11. American translation, modification, and validation of the St. George's Respiratory Questionnaire.
    Barr JT; Schumacher GE; Freeman S; LeMoine M; Bakst AW; Jones PW
    Clin Ther; 2000 Sep; 22(9):1121-45. PubMed ID: 11048909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and validity of the St George's Respiratory Questionnaire for asthma.
    Bae YJ; Kim YS; Park CS; Lee YS; Chang YS; Cho YS; Jang AS; Cho SH; Choi BW; Kim SG; Moon HB; Kim TB;
    Int J Tuberc Lung Dis; 2011 Jul; 15(7):966-71. PubMed ID: 21682973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the psychometric properties of the St George's Respiratory Questionnaire in patients with severe asthma.
    Nelsen LM; Vernon M; Ortega H; Cockle SM; Yancey SW; Brusselle G; Albers FC; Jones PW
    Respir Med; 2017 Jul; 128():42-49. PubMed ID: 28610668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
    Harrison TW; Chanez P; Menzella F; Canonica GW; Louis R; Cosio BG; Lugogo NL; Mohan A; Burden A; McDermott L; Garcia Gil E; Zangrilli JG;
    Lancet Respir Med; 2021 Mar; 9(3):260-274. PubMed ID: 33357499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative evaluation of the St George's Respiratory Questionnaire in patients with severe asthma.
    Nelsen LM; Kimel M; Murray LT; Ortega H; Cockle SM; Yancey SW; Brusselle G; Albers FC; Jones PW
    Respir Med; 2017 May; 126():32-38. PubMed ID: 28427547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric assessment of the Chinese language version of the St. George's Respiratory Questionnaire in Taiwanese patients with bronchial asthma.
    Wang KY; Chiang CH; Maa SH; Shau WY; Tarn YH
    J Formos Med Assoc; 2001 Jul; 100(7):455-60. PubMed ID: 11579610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the St George's respiratory questionnaire and risks factors affecting the quality of life of Lebanese COPD and asthma patients.
    Akiki Z; Hallit S; Layoun N; Cherfane M; Sacre H; Waked M; Salameh P
    J Asthma; 2019 Nov; 56(11):1212-1221. PubMed ID: 30359153
    [No Abstract]   [Full Text] [Related]  

  • 18. Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease.
    Solem CT; Sun SX; Sudharshan L; Macahilig C; Katyal M; Gao X
    Int J Chron Obstruct Pulmon Dis; 2013; 8():641-52. PubMed ID: 24376348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the Airway Questionnaire 20 to detect changes in quality of life in asthmatic patients and its association with the St George's Respiratory Questionnaire and clinical parameters.
    Win T; Pearce L; Nathan J; Cafferty F; Laroche C
    Can Respir J; 2008 Apr; 15(3):133-7. PubMed ID: 18437255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma.
    Chapman KR; Albers FC; Chipps B; Muñoz X; Devouassoux G; Bergna M; Galkin D; Azmi J; Mouneimne D; Price RG; Liu MC
    Allergy; 2019 Sep; 74(9):1716-1726. PubMed ID: 31049972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.